Cwm Taf Morgannwg University Health Board (CTMUHB) of NHS Wales, Roche Diagnostics, Digipharm and Life Sciences Hub Wales are launching a cutting-edge project to develop an innovative value-based contracting approach to pioneer sustainable procurement and improve the diagnosis of heart failure in patients.
All partners are working together to forge a new way of collaborative working for developing an outcome-based (payment by results) contracting model using Digipharm's blockchain platform, focusing on the value of the diagnostic test within the heart failure pathway and determining a fair payment structure based on the value generated. This will create sustainable outcomes that matter to patients and drive efficiencies for healthcare systems, with the long-term objective of creating shorter waiting times, quicker diagnostics, and better health outcomes.
The project will see procurement, clinical, operational and informatics teams at CTMUHB developing and implementing a Value-Based Health Care-led purchasing strategy for the NTproBNP diagnostic test. This is a simple and quick test developed by Roche that is used for diagnosing heart failure, which works by detecting levels of proteins that is produced by the heart when it is under stress.
To optimise its use and improve patient management and outcomes, all partners will work together to understand how this diagnostic test is currently being used within the chronic heart failure pathway.